Isac Ribeiro Moulaz

6PUBLICATIONS
51CO-AUTHORS
Condensed matter characterisation technique developmentImmunogenetics (incl. genetic immunology)Predictive and prognostic markersSensory processes, perception and performancePsychosocial aspects of childbirth and perinatal mental health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 26, 2025
Third Booster Half Dose of ChAdOx1-nCov-19 Is Effective, Safe, and Induces Long-Duration Humoral and Cellular Immune Response to Omicron: 1-Year Follow-Up of Viana Study.

Nésio Fernandes de Medeiros-Junior, Maria da Penha Gomes Gouvea, Luiz Antônio Bastos Camacho

|Jan 08, 2025
Immunogenicity and Safety According to Immunosuppressive Drugs and Different COVID-19 Vaccine Platforms in Immune-Mediated Disease: Data from SAFER Cohort.

Ketty Lysie Libardi Lira Machado, Ana Paula Neves Burian, Olindo Assis Martins-Filho

|Nov 25, 2022
Adult-onset Still's disease after ChAdOx1 nCoV-19 vaccine: a possible association.

Laíssa Fiorotti Albertino, Isac Ribeiro Moulaz, Tammer Ferreira Zogheib

|Oct 26, 2022
Anti-SARS-CoV-2 antibody immunoreactivity profiles during COVID-19 recurrence.

Maria da Penha Gomes Gouvea, Isac Ribeiro Moulaz, Thayná Martins Gouveia

|Jun 30, 2021
Pulmonary function evaluation after hospital discharge of patients with severe COVID-19.

Jessica Polese, Larissa Sant'Ana, Isac Ribeiro Moulaz

|May 10, 2021
Giant lactating adenoma.

Isac Ribeiro Moulaz, Fernanda Sales Soares de Oliveira, Eveline Cristina da Silva

Pageof 1